Financials

News Ideas Technicals

LIXT fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Lixte Biotechnology Holdings, Inc.

Total assets of LIXT for Q4 23 is 4.31 M USD, 17.69% less than the previous Q3 23. And total liabilities increased by 0.68% in Q4 23 to 313.86 k USD.

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—